RADL3 Stock Overview
Engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Raia Drogasil S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$14.85 |
| 52 Week High | R$30.40 |
| 52 Week Low | R$14.06 |
| Beta | 0.24 |
| 1 Month Change | -25.75% |
| 3 Month Change | -14.56% |
| 1 Year Change | -40.77% |
| 3 Year Change | -27.46% |
| 5 Year Change | -30.43% |
| Change since IPO | 2,160.10% |
Recent News & Updates
Raia Drogasil S.A.'s (BVMF:RADL3) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio
May 11
Raia Drogasil S.A. Just Missed Earnings - But Analysts Have Updated Their Models
May 09Recent updates
Raia Drogasil S.A.'s (BVMF:RADL3) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio
May 11Raia Drogasil S.A. Just Missed Earnings - But Analysts Have Updated Their Models
May 09Is Raia Drogasil (BVMF:RADL3) Using Too Much Debt?
Apr 29Raia Drogasil S.A. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Mar 01Raia Drogasil (BVMF:RADL3) Is Experiencing Growth In Returns On Capital
Feb 24These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well
Jan 19
RD Saude's Expansion And Digital Investment Ignite Growth In The Health Market
Expansion and digital investment aim to increase market share and boost revenue via mature store growth and new store openings.Raia Drogasil S.A.'s (BVMF:RADL3) Price In Tune With Earnings
Nov 26Earnings Beat: Raia Drogasil S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Nov 08Raia Drogasil (BVMF:RADL3) Has A Pretty Healthy Balance Sheet
Oct 13Returns Are Gaining Momentum At Raia Drogasil (BVMF:RADL3)
Sep 25Raia Drogasil S.A. Just Missed Earnings - But Analysts Have Updated Their Models
Aug 10With Raia Drogasil S.A. (BVMF:RADL3) It Looks Like You'll Get What You Pay For
Jul 13Raia Drogasil (BVMF:RADL3) Seems To Use Debt Quite Sensibly
Apr 08Does Raia Drogasil (BVMF:RADL3) Deserve A Spot On Your Watchlist?
Mar 24Investors Met With Slowing Returns on Capital At Raia Drogasil (BVMF:RADL3)
Jan 29Raia Drogasil S.A.'s (BVMF:RADL3) Earnings Haven't Escaped The Attention Of Investors
Dec 29Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?
Dec 12Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?
Nov 27Returns On Capital At Raia Drogasil (BVMF:RADL3) Have Stalled
Oct 27Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?
Sep 07Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?
Aug 19Here's What To Make Of Raia Drogasil's (BVMF:RADL3) Decelerating Rates Of Return
Jul 18Is Raia Drogasil (BVMF:RADL3) Using Too Much Debt?
Jun 03Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?
May 13Returns At Raia Drogasil (BVMF:RADL3) Appear To Be Weighed Down
Apr 10The Raia Drogasil S.A. (BVMF:RADL3) Yearly Results Are Out And Analysts Have Published New Forecasts
Mar 10Is Raia Drogasil (BVMF:RADL3) A Risky Investment?
Feb 27Returns On Capital At Raia Drogasil (BVMF:RADL3) Have Hit The Brakes
Jan 07Here's Why Raia Drogasil (BVMF:RADL3) Has Caught The Eye Of Investors
Dec 07Raia Drogasil (BVMF:RADL3) Seems To Use Debt Quite Sensibly
Nov 22Raia Drogasil (BVMF:RADL3) Could Be Struggling To Allocate Capital
Sep 08Here's Why Raia Drogasil (BVMF:RADL3) Has Caught The Eye Of Investors
Aug 24Is Raia Drogasil (BVMF:RADL3) A Risky Investment?
Aug 09There Are Reasons To Feel Uneasy About Raia Drogasil's (BVMF:RADL3) Returns On Capital
Jun 09With EPS Growth And More, Raia Drogasil (BVMF:RADL3) Is Interesting
May 25Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?
May 10Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?
Feb 24These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well
Feb 09Some Investors May Be Worried About Raia Drogasil's (BVMF:RADL3) Returns On Capital
Dec 07Should You Be Adding Raia Drogasil (BVMF:RADL3) To Your Watchlist Today?
Nov 19These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well
Nov 04Returns On Capital At Raia Drogasil (BVMF:RADL3) Paint A Concerning Picture
Sep 01Do Raia Drogasil's (BVMF:RADL3) Earnings Warrant Your Attention?
Aug 17These 4 Measures Indicate That Raia Drogasil (BVMF:RADL3) Is Using Debt Reasonably Well
Jul 28Raia Drogasil (BVMF:RADL3) Will Will Want To Turn Around Its Return Trends
May 10We Think Raia Drogasil (BVMF:RADL3) Can Stay On Top Of Its Debt
Mar 10Do Institutions Own Raia Drogasil S.A. (BVMF:RADL3) Shares?
Feb 16
Is Raia Drogasil S.A.'s (BVMF:RADL3) Recent Performance Tethered To Its Attractive Financial Prospects?
Jan 29You Have To Love Raia Drogasil S.A.'s (BVMF:RADL3) Dividend
Jan 11Did Business Growth Power Raia Drogasil's (BVMF:RADL3) Share Price Gain of 253%?
Dec 24Is Raia Drogasil (BVMF:RADL3) A Risky Investment?
Dec 03Shareholder Returns
| RADL3 | BR Consumer Retailing | BR Market | |
|---|---|---|---|
| 7D | 1.2% | 3.2% | -0.3% |
| 1Y | -40.8% | -20.4% | 6.0% |
Return vs Industry: RADL3 underperformed the BR Consumer Retailing industry which returned -20.4% over the past year.
Return vs Market: RADL3 underperformed the BR Market which returned 6% over the past year.
Price Volatility
| RADL3 volatility | |
|---|---|
| RADL3 Average Weekly Movement | 7.4% |
| Consumer Retailing Industry Average Movement | 6.3% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in BR Market | 9.8% |
| 10% least volatile stocks in BR Market | 2.8% |
Stable Share Price: RADL3's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: RADL3's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of BR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1905 | 66,275 | Renato Raduan | rdsaude.com.br |
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. It sells its products through stores, telesales, and call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.
Raia Drogasil S.A. Fundamentals Summary
| RADL3 fundamental statistics | |
|---|---|
| Market cap | R$25.44b |
| Earnings (TTM) | R$1.17b |
| Revenue (TTM) | R$39.81b |
Is RADL3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RADL3 income statement (TTM) | |
|---|---|
| Revenue | R$39.81b |
| Cost of Revenue | R$28.04b |
| Gross Profit | R$11.77b |
| Other Expenses | R$10.60b |
| Earnings | R$1.17b |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
Aug 05, 2025
| Earnings per share (EPS) | 0.69 |
| Gross Margin | 29.57% |
| Net Profit Margin | 2.95% |
| Debt/Equity Ratio | 48.8% |
How did RADL3 perform over the long term?
See historical performance and comparisonDividends
Does RADL3 pay a reliable dividends?
See RADL3 dividend history and benchmarks| Raia Drogasil dividend dates | |
|---|---|
| Ex Dividend Date | Apr 04 2025 |
| Dividend Pay Date | Dec 01 2025 |
| Days until Ex dividend | 59 days |
| Days until Dividend pay date | 182 days |
Does RADL3 pay a reliable dividends?
See RADL3 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/01 22:55 |
| End of Day Share Price | 2025/05/30 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Raia Drogasil S.A. is covered by 31 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Georgia Jorge | BB Banco de Investimento S.A. |
| Robert Ford Aguilar | BofA Global Research |
| Marcio Osako | Bradesco S.A. Corretora de Títulos e Valores Mobiliários |